VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Re : re : Hey Jackpot Acapulco

<< Previous

Bullboard Posts

Next >>

Comment by G1945Von Mar 24, 2022 8:31am

129 Views

Post# 34540680

RE:RE:Re : re : Hey Jackpot Acapulco

You say that VMS+ is "not uploaded onto Edison, I am growing weary of this"

Have we not already been told on the April 27, 2021 newswire that this has been done?

https://www.ventripoint.com/_files/ugd/8e5203_b67dc87d670446daa6edb26cb634cf11.pdf

"Ventripoint has been added as an innovator under GE Healthcare’s Edison Developer Program, which helps healthcare providers gain access to market-ready applications. As an innovator under this program, our installed base will be enhanced and will drive Ventripoint’s commercial growth worldwide by accessing GE Healthcare’s global channel."

G1945V

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario